KR100601390B1 - 혼합 생약재를 이용한 비만 억제용 조성물 - Google Patents
혼합 생약재를 이용한 비만 억제용 조성물 Download PDFInfo
- Publication number
- KR100601390B1 KR100601390B1 KR1020030097710A KR20030097710A KR100601390B1 KR 100601390 B1 KR100601390 B1 KR 100601390B1 KR 1020030097710 A KR1020030097710 A KR 1020030097710A KR 20030097710 A KR20030097710 A KR 20030097710A KR 100601390 B1 KR100601390 B1 KR 100601390B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- composition
- parts
- obesity
- extract
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 65
- 239000004615 ingredient Substances 0.000 title description 2
- 230000003579 anti-obesity Effects 0.000 title 1
- 208000008589 Obesity Diseases 0.000 claims abstract description 26
- 235000020824 obesity Nutrition 0.000 claims abstract description 26
- 239000000284 extract Substances 0.000 claims abstract description 24
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 14
- 238000004519 manufacturing process Methods 0.000 claims description 18
- 241000218671 Ephedra Species 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 230000002829 reductive effect Effects 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 11
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 9
- 239000010931 gold Substances 0.000 claims description 9
- 229910052737 gold Inorganic materials 0.000 claims description 9
- 235000013402 health food Nutrition 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 8
- 235000020224 almond Nutrition 0.000 claims description 7
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 6
- 239000011593 sulfur Substances 0.000 claims description 6
- 229910052717 sulfur Inorganic materials 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 3
- 239000000883 anti-obesity agent Substances 0.000 claims description 3
- 229940125710 antiobesity agent Drugs 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 239000004575 stone Substances 0.000 claims description 2
- 229940124597 therapeutic agent Drugs 0.000 claims description 2
- 241000220304 Prunus dulcis Species 0.000 claims 4
- 230000001476 alcoholic effect Effects 0.000 claims 1
- 239000004744 fabric Substances 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 241000411851 herbal medicine Species 0.000 abstract description 4
- 244000001632 Acorus gramineus Species 0.000 abstract 1
- 235000013073 Acorus gramineus Nutrition 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 19
- LRHPLDYGYMQRHN-UHFFFAOYSA-N butyl alcohol Substances CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 10
- 230000037396 body weight Effects 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 8
- 210000000577 adipose tissue Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 208000032843 Hemorrhage Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 206010037660 Pyrexia Diseases 0.000 description 6
- 208000034158 bleeding Diseases 0.000 description 6
- 230000000740 bleeding effect Effects 0.000 description 6
- 241000195493 Cryptophyta Species 0.000 description 5
- 238000001647 drug administration Methods 0.000 description 5
- 201000010063 epididymitis Diseases 0.000 description 5
- 239000000546 pharmaceutical excipient Substances 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000005194 fractionation Methods 0.000 description 4
- -1 lactone compounds Chemical class 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 244000144725 Amygdalus communis Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 229940124595 oriental medicine Drugs 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- UNAANXDKBXWMLN-UHFFFAOYSA-N sibutramine Chemical compound C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- YNVZDODIHZTHOZ-UHFFFAOYSA-K 2-hydroxypropanoate;iron(3+) Chemical compound [Fe+3].CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O YNVZDODIHZTHOZ-UHFFFAOYSA-K 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 244000163122 Curcuma domestica Species 0.000 description 2
- 235000003392 Curcuma domestica Nutrition 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 235000003373 curcuma longa Nutrition 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 210000000918 epididymis Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000012676 herbal extract Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 235000013976 turmeric Nutrition 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- MCJGCCFJBOZDAN-UHFFFAOYSA-N 3-butyl-1h-quinolin-2-one Chemical compound C1=CC=C2N=C(O)C(CCCC)=CC2=C1 MCJGCCFJBOZDAN-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022653 Intestinal haemorrhages Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 241000209490 Nymphaea Species 0.000 description 1
- 235000016791 Nymphaea odorata subsp odorata Nutrition 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000287107 Passer Species 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 210000000579 abdominal fat Anatomy 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000000593 adipose tissue white Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 229960004874 choline bitartrate Drugs 0.000 description 1
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000001965 increasing effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 206010038534 renal tuberculosis Diseases 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000003799 water insoluble solvent Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
성분 | g |
카제인 | 20 |
슈크로즈 | 10 |
옥수수 전분 | 31 |
덱스트로스(Dextrose) | 10 |
라드(80%) | 13.5 |
대두유 | 5.5 |
셀룰로즈 | 5 |
비타민 mix | 1 |
미네랄 mix | 3.5 |
콜린 바이타르타레이트 | 0.2 |
L-시스테인 | 0.3 |
부틸히드록시퀴놀린 | 0.0014 |
합계 | 100 |
구분 | g | cal | cal % |
탄수화물 | 51 | 204 | 47.1284 |
단백질 | 20.54 | 82.16 | 18.98073 |
지방 | 16.3 | 146.7 | 33.89087 |
합계 | 87.84 | 432.86 | 100 |
구분 | 대조군 | 실시예1 | 실시예2 | 실시예3 | 실시예4 | 실시예5 | 실시예6 | 실시예7 |
체중 (g) | 33.19 ±0.70 | 31.18 ± 0.85 | 30.72 ±0.81 | 30.94 ±0.80 | 30.61 ±0.84 | 30.42 ±0.80 | 30.12 ±0.82 | 30.03 ±0.78 |
평균 ±표준오차 |
구분 | 대조군 | 실시예1 | 실시예2 | 실시예3 | 실시예4 | 실시예5 | 실시예6 | 실시예7 |
부고환 지방조직 (g) | 2.102 ±0.097 | 1.888 ±0.134 | 1.804 ±0.094 | 1.802 ±0.081 | 1.794 ±0.096 | 1.785 ±0.091 | 1.769 ±0.085 | 1.765 ±0.092 |
신장후 지방조직 (g) | 0.782 ±0.029 | 0.715 ±0.038 | 0.709 ±0.042 | 0.703 ±0.049 | 0.698 ±0.039 | 0.687 ±0.032 | 0.681 ±0.039 | 0.679 ±0.041 |
평균 ±표준오차 |
구분 | 대조군 | 실시예1 | 실시예2 | 실시예3 | 실시예4 | 실시예5 | 실시예6 | 실시예7 |
트리 글리세라이드 (mg/dL) | 133.09 ±6.56 | 99.33 ±4.23 | 88.14 ±4.91 | 87.22 ±5.16 | 82.40 ±4.14 | 79.91 ±4.45 | 75.47 ±5.05 | 75.41 ±4.92 |
평균 ±표준오차 |
구분 | 대조군 | 리덕틸 | 실시예1 | 실시예2 | 실시예3 | 실시예4 | 실시예5 | 실시예6 | 실시예7 |
체중 (g) | 63.22 ±1.87 | 57.69 ±0.92 | 58.21 ±1.12 | 57.91 ±1.07 | 57.31 ±1.85 | 57.1 ±1.01 | 57.13 ±1.73 | 56.82 ±1.27 | 56.41 ±1.15 |
평균±표준오차 |
Claims (8)
- 건조중량비로 마황, 황금 및 포황을 각각 30 ∼ 60 중량부 포함하는 것을 특징으로 하는 비만억제용 조성물.
- 제 1 항에 있어서, 추가적으로 석창포 30 ~ 60 중량부, 행인 30 ~ 60 중량부, 하엽 15 ~ 45 중량부 및 원지 15 ~ 45 중량부 중에서 선택된 1종, 2종 또는 3종을 포함하는 것을 특징으로 하는 비만억제용 조성물.
- 제 1 항 또는 제 2 항의 조성물을 유효성분으로 함유하는 것을 특징으로 하는 비만 치료제.
- 제 1 항 또는 제 2 항의 조성물을 함유하는 것을 특징으로 하는 건강식품.
- 건조중량비로 마황, 황금 및 포황을 각각 30 ~ 60 중량부 혼합한 다음, 열수 추출하는 단계, 상기 추출액을 감압 농축 후 동량의 저급 알코올로 층분리하여 감압 농축하는 단계와, 상기 농축단계에서 얻어진 엑기스를 물로 공비농축하고 동결건조하여 분말엑기스를 제조하는 것을 특징으로 하는 비만억제용 조성물의 제조방법.
- 제 5 항에 있어서, 건조중량비로 석창포 30 ∼ 60 중량부, 행인 30 ∼ 60 중량부, 하엽 15 ∼ 45 중량부 및 원지 15 ∼ 45 중량부 중에서 선택된 1종 이상을 추가하여 혼합하는 것을 특징으로 하는 비만억제용 조성물의 제조방법.
- 건조중량비로 마황, 황금 및 포황을 각각 30 ~ 60 중량부로 혼합한 다음, 알코올성 수용액으로 환류 추출하는 단계, 상기 추출액을 감압 농축하여 알코올을 제거한 후 동량의 저급 알코올로 층분리하고, 상기 농축단계에서 얻어진 엑기스를 물로 공비농축하고 동결건조하여 분말엑기스를 제조하는 것을 특징으로 하는 비만억제용 조성물의 제조방법.
- 제 7 항에 있어서, 상기 석창포 30 ∼ 60 중량부, 행인 30 ∼ 60 중량부, 하엽 15 ∼ 45 중량부 및 원지 15 ∼ 45 중량부 중에서 선택된 1종 이상을 추가하여 혼합하는 것을 특징으로 하는 비만억제용 조성물의 제조방법.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20020085058 | 2002-12-27 | ||
KR1020020085058 | 2002-12-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040060808A KR20040060808A (ko) | 2004-07-06 |
KR100601390B1 true KR100601390B1 (ko) | 2006-07-13 |
Family
ID=36081151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020030097710A KR100601390B1 (ko) | 2002-12-27 | 2003-12-26 | 혼합 생약재를 이용한 비만 억제용 조성물 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1583547B1 (ko) |
JP (1) | JP2006514041A (ko) |
KR (1) | KR100601390B1 (ko) |
CN (1) | CN100488540C (ko) |
AT (1) | ATE443522T1 (ko) |
AU (1) | AU2003289535A1 (ko) |
DE (1) | DE60329423D1 (ko) |
HK (1) | HK1087626A1 (ko) |
WO (1) | WO2004058284A1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101045640B1 (ko) | 2008-06-23 | 2011-06-30 | 학교법인 동의학원 | 마황과 마우의 혼합물을 유효성분으로 포함하는 안전성이개선된 항비만용 조성물 |
KR101207991B1 (ko) * | 2008-10-20 | 2012-12-04 | 남일농장인삼 영농조합법인 | 비만 및 대사성 질환 예방 또는 치료용 조성물 |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5105890B2 (ja) * | 2007-02-06 | 2012-12-26 | 株式会社 資生堂 | Vegfc産生促進剤 |
CN101444614B (zh) * | 2008-12-31 | 2011-04-20 | 宫守汪 | 具有燃脂紧肤作用的药物组合物及其制备方法 |
KR101621447B1 (ko) * | 2013-06-18 | 2016-06-01 | 한국 한의학 연구원 | 삼백초, 강황 및 원지의 복합추출물을 포함하는 비만의 예방 또는 치료용 약학 조성물 |
EP3023103A1 (en) * | 2014-11-19 | 2016-05-25 | Korea Institute of Oriental Medicine | Pharmaceutical composition for anti-obesity comprising complex extracts including Saururi chinensis Baill. extract, Curcumae longae rhizoma extract and Polygalae radix extract |
JP6047545B2 (ja) * | 2014-12-09 | 2016-12-21 | コリア インスティテュート オブ オリエンタル メディシン | サンパクソウ、キョウオウ及びオンジの複合抽出物を含む、肥満の予防又は治療用薬学組成物 |
KR102232076B1 (ko) * | 2017-12-29 | 2021-03-25 | 주식회사 누베베 | 사상의학에 따라 처방가능한 한약 비만치료 타블릿의 제조방법 |
KR101888478B1 (ko) * | 2018-02-23 | 2018-08-14 | 주식회사 위드내추럴 | 한약재를 이용한 체중감량용 조성물 |
US20240189226A1 (en) * | 2021-04-16 | 2024-06-13 | University-Industry Cooperation Group Of Kyung Hee University | Pharmaceutical composition for preventing or treating obesity or non-alcoholic fatty liver containing polygalin c as active ingredient |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1043625A (zh) * | 1988-12-23 | 1990-07-11 | 杭文敬 | 健美减肥精 |
JPH08198769A (ja) * | 1995-01-23 | 1996-08-06 | Pola Chem Ind Inc | 過剰栄養吸収抑制剤及びそれを含有する組成物 |
US5985282A (en) * | 1997-01-22 | 1999-11-16 | Hpf, L.L.C. | Herbal appetite suppressant and weight loss composition |
KR19980067315A (ko) * | 1997-02-03 | 1998-10-15 | 김달래 | 뚱뚱한 사람이 섭취하는 다이어트 건강식품의 제조방법 |
CN1127306C (zh) * | 1998-11-29 | 2003-11-12 | 李恩洪 | 绿色生物功能饮料的制造方法 |
CN1081442C (zh) * | 1999-01-29 | 2002-03-27 | 程顺民 | 一种山芪茶 |
KR100335564B1 (ko) * | 1999-08-09 | 2002-05-08 | 성재갑 | 성장호르몬 분비촉진 소재를 함유한 체지방 감소용 다이어트 식품 조성물 |
AU2000229021A1 (en) * | 2000-02-29 | 2001-09-12 | Jun Ho Co., Ltd. | A medicine for treating obesity and the method of producing thereof |
KR100399529B1 (ko) * | 2000-05-23 | 2003-09-26 | 제노마인(주) | 생약 추출물을 포함하는 콜레스테롤 에스터레이즈 저해제조성물 |
US6475530B1 (en) * | 2000-05-31 | 2002-11-05 | Eric H. Kuhrts | Methods and compositions for producing weight loss |
CN1311032A (zh) * | 2001-02-28 | 2001-09-05 | 华良药业有限公司 | 一种减肥降脂茶及其制备方法 |
KR100422214B1 (ko) * | 2001-08-27 | 2004-03-11 | (주)헬퍼랩 | 생약성분을 함유하는 비만방지 차 조성물 |
KR20030081189A (ko) * | 2002-04-13 | 2003-10-17 | 이응세 | 비타민 복합제 및 생약 추출물을 함유하는 고지혈증 및동맥경화증 예방 및 치료를 위한 조성물 |
-
2003
- 2003-12-26 WO PCT/KR2003/002852 patent/WO2004058284A1/en active Application Filing
- 2003-12-26 AT AT03779025T patent/ATE443522T1/de not_active IP Right Cessation
- 2003-12-26 AU AU2003289535A patent/AU2003289535A1/en not_active Abandoned
- 2003-12-26 KR KR1020030097710A patent/KR100601390B1/ko active IP Right Grant
- 2003-12-26 CN CNB2003801089281A patent/CN100488540C/zh not_active Expired - Fee Related
- 2003-12-26 DE DE60329423T patent/DE60329423D1/de not_active Expired - Fee Related
- 2003-12-26 JP JP2004563018A patent/JP2006514041A/ja active Pending
- 2003-12-26 EP EP03779025A patent/EP1583547B1/en not_active Expired - Lifetime
-
2006
- 2006-07-14 HK HK06107869.7A patent/HK1087626A1/xx not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101045640B1 (ko) | 2008-06-23 | 2011-06-30 | 학교법인 동의학원 | 마황과 마우의 혼합물을 유효성분으로 포함하는 안전성이개선된 항비만용 조성물 |
KR101207991B1 (ko) * | 2008-10-20 | 2012-12-04 | 남일농장인삼 영농조합법인 | 비만 및 대사성 질환 예방 또는 치료용 조성물 |
Also Published As
Publication number | Publication date |
---|---|
HK1087626A1 (en) | 2006-10-20 |
AU2003289535A8 (en) | 2004-07-22 |
EP1583547A1 (en) | 2005-10-12 |
DE60329423D1 (de) | 2009-11-05 |
CN100488540C (zh) | 2009-05-20 |
AU2003289535A1 (en) | 2004-07-22 |
ATE443522T1 (de) | 2009-10-15 |
CN1738633A (zh) | 2006-02-22 |
WO2004058284A1 (en) | 2004-07-15 |
EP1583547B1 (en) | 2009-09-23 |
EP1583547A4 (en) | 2007-07-18 |
JP2006514041A (ja) | 2006-04-27 |
KR20040060808A (ko) | 2004-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102078473B (zh) | 一种治疗慢性乙型肝炎的中药制剂及其制备方法 | |
CN101612362B (zh) | 一种调节血脂、防治心脑血管疾病复方制剂及其制备方法 | |
CN102145064A (zh) | 一种治疗老年性阴道炎的中药组合物及其制备方法 | |
KR100601390B1 (ko) | 혼합 생약재를 이용한 비만 억제용 조성물 | |
CN104815192A (zh) | 一种治疗高血压的药物组合物及其应用 | |
CN103690582B (zh) | 一种含石斛多糖和苍术硬脂的组合物及其应用 | |
CN102178781B (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法 | |
KR101600751B1 (ko) | 녹용을 함유하는 여성 불임증 치료용 한약 조성물 제조 방법 | |
KR20190033828A (ko) | 생약 추출물을 포함하는 고요산혈증 또는 고요산혈증 관련 대사 장애의 예방, 개선 또는 치료용 조성물 | |
KR20150033797A (ko) | 아토피성 피부질환 예방 및 치료용 약학적 조성물 | |
CN108159204B (zh) | 一种具有解毒保肝作用的藏药组合物 | |
CN105596587A (zh) | 用于消肿止痛的组合物 | |
KR102613167B1 (ko) | 중약 조성물 및 그 방법과 응용 | |
CN112057535B (zh) | 一种预防或/和治疗血脂异常的中药组合物的制备方法 | |
KR101698869B1 (ko) | 한약재를 유효성분으로 함유하는 아토피 피부염 예방 또는 치료용 조성물 | |
CN100579564C (zh) | 一种治疗痛风的药物及其制备方法 | |
KR100678519B1 (ko) | 다슬기, 유황오리, 유근피, 송화가루, 산청목, 죽염,인진쑥, 도라지 및 흑두로 구성되는 복합제 추출물을포함하는 지방간 예방 및 치료를 위한 조성물 | |
KR101934810B1 (ko) | 한방 생약 추출물을 포함하는 혈행 개선용 제제 | |
KR100468054B1 (ko) | 비만억제용 조성물 | |
CN107029124B (zh) | 一种用于治疗原发性高血压的中药组合物及其制备方法 | |
KR20040008975A (ko) | 뇌기능 및 인지 기능 개선 활성을 갖는 조성물 | |
KR100712659B1 (ko) | 당뇨병 및 이로 인한 합병증 치료 및 예방용 한약조성물 | |
CN112057536B (zh) | 一种预防或/和治疗血脂异常的中药组合物及其应用 | |
KR100773246B1 (ko) | 연령초 추출물을 유효성분으로 함유하는 비만 억제 및 혈당강하용 조성물 | |
KR20140044078A (ko) | 항비만 활성을 나타내는 정유(essential oil) 분획물을 제조하는 제조방법 및 이 분획물을 포함하는 지방간 및 비만 예방 및 치료효과를 갖는 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130702 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140704 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150703 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160704 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170710 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180704 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190708 Year of fee payment: 14 |